CD34 and neoplasm: Semiquantitative assessment of the proportion of CD34+ fibroblasts in the tumor stroma of invasive lobular carcinoma of the breast showed no statistically significant difference for tumor size, pT stage, grading, distant metastasis until December 2018, or tumor type (Table 2).